SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: a clinicopathologic study of 35 cases. Arch Dermatol. 1983; 119: 104114.
  • 2
    Hirsh LF, Enterline HT, Rosato EF, Rosato FE. Sweat gland carcinoma. Ann Surg. 1971; 174: 283286.
  • 3
    El-Domeiri AA, Brasfield RD, Huvos AG, Strong EW. Sweat gland carcinoma: a clinico-pathology study of 83 patients. Ann Surg. 1971; 173: 270274.
  • 4
    Jacobson YG, Rees TD, Grant R, Fitchett VH. Metastasizing sweat-gland carcinoma. Arch Surg. 1959; 78: 574581.
  • 5
    Murphy GF, Elder DE. Cutaneous appendage tumors. In: MurphyGF, ElderDE, editors. Atlas of tumor pathology: non-melanocytic tumors of the skin. Washington, DC: Armed Forces Institute of Pathology, 1990: 90107.
  • 6
    Shaw J, Koea J. Morbidity of lymphadenectomy for melanoma. Surg Oncol Clin N Am. 1992; 1: 195204.
  • 7
    Cochran AJ, Balda B, Starz H, et al. The Augsburg consensus: techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer. 2000; 89: 236241.
  • 8
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992; 127: 392399.
  • 9
    Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996; 223: 217224.
  • 10
    Giuliano AK, Kirgen DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220: 391401.
  • 11
    Kelemen PR, van Herle AJ, Giuliano AK. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg. 1998; 133: 288292.
  • 12
    Koops HS, Doting MH, de Vries J, et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol. 1999; 51: 17.
  • 13
    Rodrigues LKE, Leong SPL, Kashani-Sabet M, Wong JH. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol. 2001; 45: 303308.
  • 14
    Su LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol. 2002; 46(5): 661666.
  • 15
    Malafa MP, McKesey P, Stone S, Dudley-Walker S, Cockerell CJ. Sentinel node biopsy for staging of aggressive digital papillary adenocarcinoma. Dermatol Surg. 2000; 26: 580583.
  • 16
    O'Brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphscintigraphy. Am J Surg. 1995; 170: 461466.
  • 17
    Kao GF, Helwig EB, Graham JH. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations. J Cutan Pathol. 1987; 14: 129146.
  • 18
    Massad LS, Bitterman P, Clarke-Pearson DL. Metastatic clear cell eccrine hidradenocarcinoma of the vulva: survival after primary surgical resection. Gynecol Oncol. 1996; 61: 287290.
  • 19
    Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol. 1987; 4: 3874.
  • 20
    Evans AT, Parham DM, Van Niekerk LJA. Metastasizing eccrine syringomatous carcinoma: a case report. Histopathology. 1995; 26: 185187.
  • 21
    Gomez Orbaneja J, Sanchez Yus E, Diaz-Flores L, Hernandez Moro J. Adenocarcinom der ekkrinen Schweissdrussen Klinische, histopathologische, histoenzymatische und ultrastructurelle Untersuchung eines Falles. Hautartz. 1973; 24: 197202.
  • 22
    Alegre VA, Hernandez M, Aliaga A. Metastatic eccrine epithelioma. J Cutan Pathol. 1986; 13: 433.